menu
    • menu

    Company profile for GT Biopharma

    NEW Drugs in Dev: 6
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary Tri-specific Killer Engager (TriKE™) platform. Our TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement wi...
    GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary Tri-specific Killer Engager (TriKE™) platform. Our TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize cancer therapies using proprietary TriKE technology developed by researchers at the university to target NK cells to cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GT BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9350 Wilshire Blvd Suite 203 Beverly Hills, CA 90212
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gtbiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Functional Force Platforms to Disrupt Tumors by 2026
    Functional Force Platforms to Disrupt Tumors by 2026

    16 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/functional-force-precision-platforms-disrupt-the-2026-tumor-landscape-302663334.html

    PR NEWSWIRE
    16 Jan 2026
    Share Share
    GT Bio Submits IND For B7-H3-Targeted Trike In Solid Tumor Cancer
    GT Bio Submits IND For B7-H3-Targeted Trike In Solid Tumor Cancer

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219554/0/en/GT-Biopharma-Announces-IND-Submission-for-GTB-5550-TriKE-a-B7-H3-targeted-natural-killer-NK-cell-engager-for-B7-H3-expressing-solid-tumor-cancers.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    GT Biopharma's Phase 1 Advance Signals Near-Term Catalyst
    GT Biopharma's Phase 1 Advance Signals Near-Term Catalyst

    19 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-19/gt-biopharma-inc-nasdaqgtbp-offers-near-term-catalyst-opportunity-with-advancing-phase-1-trials

    PHARMIWEB
    19 Nov 2025
    Share Share
    GT Bio Reports Q3 2025 Financials & Corporate Update
    GT Bio Reports Q3 2025 Financials & Corporate Update

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188344/0/en/GT-Biopharma-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    GT Bio Updates Enrollment In GTB-3650 Phase 1 Trial For R/R CD33
    GT Bio Updates Enrollment In GTB-3650 Phase 1 Trial For R/R CD33

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172103/0/en/GT-Biopharma-Provides-Enrollment-Update-on-GTB-3650-Phase-1-Trial-in-Patients-with-Relapsed-or-Refractory-r-r-CD33-Expressing-Hematologic-Malignancies.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Next-Gen Targeted Therapies Transform Oncology Precision Care
    Next-Gen Targeted Therapies Transform Oncology Precision Care

    15 Oct 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/next-generation-targeted-therapies-reshape-precision-oncology-landscape-302584906.html

    PR NEWSWIRE BIO
    15 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search